Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
Claudio Counoupas, Matt D. Johansen, Alberto Ospina Stella, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers
Laure F. Pittet, Nicole L. Messina, Francesca Orsini, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 17, pp. 1582-1596
Open Access | Times Cited: 85
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 2
Open Access | Times Cited: 92
Trained immunity-related vaccines: innate immune memory and heterologous protection against infections
Athanasios Ziogas, Mihai G. Netea
Trends in Molecular Medicine (2022) Vol. 28, Iss. 6, pp. 497-512
Closed Access | Times Cited: 56
Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
Matt D. Johansen, Rashad M. Mahbub, Sobia Idrees, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 712-729
Open Access | Times Cited: 45
The role of trained immunity in COVID-19: Lessons for the next pandemic
Mihai G. Netea, Athanasios Ziogas, Christine Stabell Benn, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 890-901
Open Access | Times Cited: 35
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y. Henry, Matt D. Johansen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2
Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
Nicole L. Messina, Susie Germano, Rebecca McElroy, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 33
The rapid progress in COVID vaccine development and implementation
Alan D.T. Barrett, Richard W. Titball, Paul A. MacAry, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 27
A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice
Duo Li, Weiran Li, Zheng Peng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19
C Noble, Nicole L. Messina, Laure F. Pittet, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1467-1478
Open Access | Times Cited: 17
Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum protective immune response against SARS-CoV-2 variants
Weiqi Wang, Xianyong Meng, Huan Cui, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130820-130820
Closed Access | Times Cited: 6
Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, et al.
World Journal of Virology (2022) Vol. 11, Iss. 5, pp. 221-236
Open Access | Times Cited: 27
Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis
Rachel E. Hildebrand, S Chandrasekar, Mariah Riel, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 26
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2408-2408
Open Access | Times Cited: 24
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
Nicole L. Messina, Susie Germano, Amy W. Chung, et al.
Clinical & Translational Immunology (2025) Vol. 14, Iss. 1
Open Access
Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance
Kerry L. Hilligan, Patricia A. Darrah, Robert A. Seder, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 4
Closed Access
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine
Anna Dalla Pietà, Bruno Martorelli Di Genova, Alessandro Penna, et al.
Journal of Controlled Release (2025), pp. 113674-113674
Closed Access
BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents
Wenping Gong, Yingqing Mao, Yuexi Li, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108870-108870
Open Access | Times Cited: 19
Recombinant Bacillus Calmette–Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge
Fábio Mambelli, Fábio V. Marinho, Juvana Moreira Andrade, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 12, pp. 1925-1937
Open Access | Times Cited: 11
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
Karin Dijkman, Thomas Lindenstrøm, Ida Rosenkrands, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
Alok Kumar Singh, Rulin Wang, Kara A. Lombardo, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107733-107733
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top